Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.33
0.22 (19.82%)
At close: Aug 14, 2025, 3:59 PM
1.34
0.74%
Pre-market: Aug 15, 2025, 04:27 AM EDT
19.82% (1D)
| Bid | 1.25 |
| Market Cap | 109.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -35.79M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -3.91 |
| Forward PE | -2.39 |
| Analyst | Buy |
| Ask | 1.37 |
| Volume | 3,478,275 |
| Avg. Volume (20D) | 460,404 |
| Open | 1.17 |
| Previous Close | 1.11 |
| Day's Range | 1.16 - 1.35 |
| 52-Week Range | 0.77 - 2.63 |
| Beta | 0.79 |
About CRDL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRDL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+14.75%
Cardiol Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
10 months ago
-6.63%
Cardiol Therapeutics shares are trading lower after the company announced a $13.5 million public offering of 8,437,500 common shares priced at $1.60 per unit.
2 months ago · newsfilecorp.com
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of ShareholdersToronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti...
